Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Vertex Pharmaceuticals Inc. buy Wolfe Research

Vertex Pharmaceuticals Inc.
Start price
€393.55
15.02.24 / 50%
Target price
€478.13
15.02.25
Performance (%)
11.82%
End price
€440.05
16.02.25
Summary
This prediction ended on 16.02.25 with a price of €440.05. The prediction had a final performance of 11.82%. Wolfe_Research has a follow-up prediction for Vertex Pharmaceuticals Inc. where he still thinks Vertex Pharmaceuticals Inc. is a Buy. Wolfe_Research has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Vertex Pharmaceuticals Inc. 2.116% 2.116% -5.654%
iShares Core DAX® -3.520% -4.987% 1.926%
iShares Nasdaq 100 0.261% 1.102% 15.434%
iShares Nikkei 225® -4.953% -3.352% 29.010%
iShares S&P 500 -0.823% -0.042% 10.814%

Comments by Wolfe_Research for this prediction

In the thread Trading Vertex Pharmaceuticals Inc.
Prediction Buy
Perf. (%) 11.82%
Target price 478.126
Change
Ends at 15.02.25

Die von Wolfe_Research gewählte maximale Laufzeit wurde überschritten

Wolfe Research 
0
Report Share
16.02.25
In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 11.82%
Target price 478.126
Change
Ends at 15.02.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $515.00 price target on the stock.
Ratings data for VRTX provided by MarketBeat

Wolfe Research 
0
Report Share
15.02.24

Current prediction by Wolfe_Research for Vertex Pharmaceuticals Inc.

buy
Vertex Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€389.95
06.01.26
€467.39
06.01.27
10.37%
16:55

Wolfe Research 
06.01.26 50%